- Home
- CTXR vs CRIS Comparison
CTXR vs CRIS Comparison
Compare CTXR & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- CRIS
- Stock Information
- Founded
- CTXR 2007
- CRIS 2000
- Country
- CTXR United States
- CRIS United States
- Employees
- CTXR N/A
- CRIS N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTXR Health Care
- CRIS Health Care
- Exchange
- CTXR Nasdaq
- CRIS Nasdaq
- Market Cap
- CTXR 14.6M
- CRIS 13.5M
- IPO Year
- CTXR N/A
- CRIS 2000
- Fundamental
- Price
- CTXR $0.94
- CRIS $2.00
- Analyst Decision
- CTXR Strong Buy
- CRIS Strong Buy
- Analyst Count
- CTXR 2
- CRIS 3
- Target Price
- CTXR $54.50
- CRIS $21.00
- AVG Volume (30 Days)
- CTXR 142.3K
- CRIS 106.4K
- Earning Date
- CTXR 05-23-2025
- CRIS 05-06-2025
- Dividend Yield
- CTXR N/A
- CRIS N/A
- EPS Growth
- CTXR N/A
- CRIS N/A
- EPS
- CTXR N/A
- CRIS N/A
- Revenue
- CTXR N/A
- CRIS $11,202,000.00
- Revenue This Year
- CTXR N/A
- CRIS $2.62
- Revenue Next Year
- CTXR N/A
- CRIS $9.84
- P/E Ratio
- CTXR N/A
- CRIS N/A
- Revenue Growth
- CTXR N/A
- CRIS 14.17
- 52 Week Low
- CTXR $0.68
- CRIS $1.02
- 52 Week High
- CTXR $26.25
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- CTXR 51.36
- CRIS 51.33
- Support Level
- CTXR $0.65
- CRIS $1.06
- Resistance Level
- CTXR $0.82
- CRIS $2.45
- Average True Range (ATR)
- CTXR 0.09
- CRIS 0.31
- MACD
- CTXR 0.04
- CRIS 0.03
- Stochastic Oscillator
- CTXR 85.69
- CRIS 37.50
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.